BRENZAVVY
NDC 82381-2174, Bexagliflozin, tablet, from TheracosBio, LLC.
- Product NDC
- 82381-2174
- Status
- Listed
- Labeler
- TheracosBio, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214373
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82381-2174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BEXAGLIFLOZIN20 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82381-2174-1 | 82381217401 | 30 TABLET in 1 BOTTLE (82381-2174-1) |
| 82381-2174-2 | 82381217402 | 90 TABLET in 1 BOTTLE (82381-2174-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3cdf28fc-4194-4ad6-aa03-c9eaa68da83e
Use it
Look up 82381-2174 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82381-2174 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82381-2174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.